Clinical trial
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced…
NCT00066612 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00066612 |
|---|---|
| Title | S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy |
| Official title | Phase II Study of Irinotecan in Patients With Advanced Transitional Cell Carcinoma of the Urothelium |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Enrollment | 45 |
| Start date | Jul 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | May 1, 2010 |
| First posted | Aug 7, 2003 |
| Last update posted | Nov 2, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: